207 related articles for article (PubMed ID: 37346066)
1. Prognostic and predictive significance of circulating biomarkers in patients with advanced upper gastrointestinal cancer undergoing systemic chemotherapy.
Li N; Gao L; Ge Y; Zhao L; Bai C; Wang Y
Front Oncol; 2023; 13():1195848. PubMed ID: 37346066
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of inflammatory markers and clinical features for survival in advanced or metastatic esophageal squamous cell carcinoma patients receiving anti-programmed death 1 treatment.
Da L; Qu Z; Zhang C; Shen Y; Huang W; Zhang Y; Gu K
Front Oncol; 2023; 13():1144875. PubMed ID: 37035159
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of esophageal cancer immune prognostic index in advanced esophageal squamous cell carcinoma patients with anti-programmed cell death-1 therapy.
Lu J; Du L; Lei X; Zhang Z
Cancer Med; 2023 May; 12(10):11334-11343. PubMed ID: 36951584
[TBL] [Abstract][Full Text] [Related]
4. Association of lymphocyte subsets with efficacy and prognosis of immune checkpoint inhibitor therapy in advanced non-small cell lung carcinoma: a retrospective study.
Yan Y; Wang X; Liu C; Jia J
BMC Pulm Med; 2022 Apr; 22(1):166. PubMed ID: 35484541
[TBL] [Abstract][Full Text] [Related]
5. Peripheral blood lymphocyte subsets predict the efficacy of TACE with or without PD-1 inhibitors in patients with hepatocellular carcinoma: a prospective clinical study.
Wang H; Huang H; Liu T; Chen Y; Li J; He M; Peng J; Liang E; Li J; Liu W
Front Immunol; 2024; 15():1325330. PubMed ID: 38404585
[TBL] [Abstract][Full Text] [Related]
6. The predictive and prognostic role of a novel ADS score in esophageal squamous cell carcinoma patients undergoing esophagectomy.
Gao QF; Qiu JC; Huang XH; Xu YM; Li SQ; Sun F; Zhang J; Yang WM; Min QH; Jiang YH; Chen QG; Zhang L; Wang XZ; Ying HQ
Cancer Cell Int; 2018; 18():153. PubMed ID: 30305803
[TBL] [Abstract][Full Text] [Related]
7. Predictive and Prognostic Role of Peripheral Blood T-Cell Subsets in Triple-Negative Breast Cancer.
Li M; Xu J; Jiang C; Zhang J; Sun T
Front Oncol; 2022; 12():842705. PubMed ID: 35242718
[TBL] [Abstract][Full Text] [Related]
8. Chemoradiotherapy-Induced CD4
Chen X; Zhang W; Qian D; Guan Y; Wang Y; Zhang H; Er P; Yan C; Li Y; Ren X; Pang Q; Wang P
Front Oncol; 2019; 9():73. PubMed ID: 30828566
[No Abstract] [Full Text] [Related]
9. Post treatment NLR is a predictor of response to immune checkpoint inhibitor therapy in patients with esophageal squamous cell carcinoma.
Wu X; Han R; Zhong Y; Weng N; Zhang A
Cancer Cell Int; 2021 Jul; 21(1):356. PubMed ID: 34233686
[TBL] [Abstract][Full Text] [Related]
10. Nomogram Based on Monocyte-to-Lymphocyte Ratio to Predict Survival of Unresectable Esophageal Squamous Cell Carcinoma Who Receive First-Line PD-1/PD-L1 Inhibitors Combined with Chemotherapy.
Ma X; Ding Y; Qian J; Wan M; Li N; Mao C; Xiao C; Jiang H; Zheng Y; Wu L; Chen X; Xu N
Curr Oncol; 2022 Nov; 29(11):8937-8954. PubMed ID: 36421355
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of peripheral CD8+CD28+ and CD8+CD28- T cells in advanced non-small cell lung cancer patients treated with chemo(radio)therapy.
Liu C; Jing W; An N; Li A; Yan W; Zhu H; Yu J
J Transl Med; 2019 Oct; 17(1):344. PubMed ID: 31623615
[TBL] [Abstract][Full Text] [Related]
12. CD3+/CD4+ cells combined with myosteatosis predict the prognosis in patients who underwent gastric cancer surgery.
Du Z; Xiao Y; Deng G; Song H; Xue Y; Song H
J Cachexia Sarcopenia Muscle; 2024 Jun; ():. PubMed ID: 38894548
[TBL] [Abstract][Full Text] [Related]
13. Circulating activated immune cells as a potential blood biomarkers of non-small cell lung cancer occurrence and progression.
Wang Y; Zhou N; Zhu R; Li X; Sun Z; Gao Y; Liu W; Meng C; Ge Y; Bai C; Li T; Liu H
BMC Pulm Med; 2021 Sep; 21(1):282. PubMed ID: 34488711
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy.
Lee S; Oh SY; Kim SH; Lee JH; Kim MC; Kim KH; Kim HJ
BMC Cancer; 2013 Jul; 13():350. PubMed ID: 23876227
[TBL] [Abstract][Full Text] [Related]
15. Circulating memory PD-1
Liu J; Liu D; Hu G; Wang J; Chen D; Song C; Cai Y; Zhai C; Xu W
Cancer Cell Int; 2023 Nov; 23(1):274. PubMed ID: 37974194
[TBL] [Abstract][Full Text] [Related]
16. Pretreatment NRS-2002 scores combined with hematologic inflammation markers are independent prognostic factors in patients with resectable thoracic esophageal squamous cell carcinoma.
Guo XW; Liu YC; Gao F; Ji SJ; Zhou JY; Ji L; Zhou SB
Cancer Manag Res; 2018; 10():2409-2418. PubMed ID: 30122990
[TBL] [Abstract][Full Text] [Related]
17. Association of lymphocyte subsets with the efficacy and prognosis of PD‑1 inhibitor therapy in advanced gastric cancer: results from a monocentric retrospective study.
Wang X; Liu X; Dai H; Jia J
BMC Gastroenterol; 2024 Mar; 24(1):113. PubMed ID: 38491354
[TBL] [Abstract][Full Text] [Related]
18. High expression of programmed cell death protein 1 on peripheral blood T-cell subsets is associated with poor prognosis in metastatic gastric cancer.
Shi B; Li Q; Ma X; Gao Q; Li L; Chu J
Oncol Lett; 2018 Oct; 16(4):4448-4454. PubMed ID: 30214579
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio in patients with metastatic gastric cancer.
Zhao G; Liu N; Wang S; Guo J; Song X; Qi Y; Qiu W; Lv J
Medicine (Baltimore); 2020 Mar; 99(10):e19405. PubMed ID: 32150090
[TBL] [Abstract][Full Text] [Related]
20. Association of Peripheral Blood Biomarkers With Response to Anti-PD-1 Immunotherapy for Patients With Deficient Mismatch Repair Metastatic Colorectal Cancer: A Multicenter Cohort Study.
Cheng YK; Chen DW; Chen P; He X; Li PS; Lin ZS; Chen SX; Ye SB; Lan P
Front Immunol; 2022; 13():809971. PubMed ID: 35185898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
